Glaucoma Surgery Devices Market is projected to reach US$ 6.0 billion by 2031

The Glaucoma Surgery Devices Market is expected to grow at a CAGR of 24.2% during the forecast period 2024 to 2031. 

Glaucoma surgery devices primarily target the reduction of intraocular pressure (IOP), a pivotal modifiable risk factor in glaucoma management. By effectively lowering IOP, these devices play a crucial role in halting or mitigating the progression of the disease, thereby preventing further damage to the optic nerve. Consequently, the primary goal of glaucoma therapy is to alleviate intraocular pressure. 

The exponential growth of the glaucoma surgery devices market can be attributed to several key factors. Firstly, there is a notable increase in the prevalence of glaucoma cases globally, compounded by the rising geriatric population, which is particularly vulnerable to ocular diseases. Additionally, there is a growing demand for minimally invasive glaucoma surgery (MIGS) procedures, driven by their effectiveness and patient preference.  

Furthermore, continuous technological advancements in glaucoma surgery devices are expected to further fuel market growth, catering to the evolving needs of patients and healthcare providers alike. 

For More Insights Request Free Sample: https://www.datamintelligence.com/download-sample/glaucoma-surgery-devices-market 

Glaucoma Surgery Devices Market Trends 

The rise in the prevalence of eye diseases stands out as a significant driver fueling market growth during the forecast period. As per data from the World Health Organization (WHO), a staggering 2.2 billion individuals globally suffer from either near or far vision impairment. Alarmingly, nearly half of these cases, equating to approximately 1 billion people, could have either been prevented or corrected. 

Among this affected population, the 1 billion figure encompasses individuals grappling with moderate to severe distance vision impairment or blindness attributable to uncorrected refractive error (88.4 million), cataracts (94 million), age-related macular degeneration (8 million), glaucoma (7.7 million), diabetic retinopathy (3.9 million), and near vision impairment arising from uncorrected presbyopia (826 million). 

These statistics underscore the pressing need for effective interventions and solutions to address the growing burden of eye diseases globally. As the prevalence of these conditions continues to rise, the demand for innovative treatments, diagnostic tools, and therapeutic interventions within the eye care sector is expected to experience significant growth, thereby propelling the overall market forward. 

View Full Report: https://www.datamintelligence.com/research-report/glaucoma-surgery-devices-market 

Market Segmentation 

By Product Type 

By Surgery Type 

By End User 

Market Players 

Major players are Ziemer Ophthalmic Systems AG, Corza Medical, Alcon, Inami & Co Ltd, Katalyst Surgical, Lumenis, Millennium Surgical, Moria Surgical, Zabbys and Allergan.